Cardiovascular disease (CVD) is a potential adverse effect of endocrine treatment (ET) for prostate cancer (PC). We investigated absolute and relative CVD risk in 76,600 patients with PC undergoing ET ...
Cancer risk and overall survival in APC I1307K carriers. Results of a prospective phase II national study: Prophylactic radical fimbriectomy (NCT01608074), in women with a documented high risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results